These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 27734394)

  • 41. The matri-cellular proteins 'cysteine-rich, angiogenic-inducer, 61' and 'connective tissue growth factor' are regulated in experimentally-induced sepsis with multiple organ dysfunction.
    Hviid CV; Erdem JS; Kunke D; Ahmed SM; Kjeldsen SF; Wang YY; Attramadal H; Aasen AO
    Innate Immun; 2012 Oct; 18(5):717-26. PubMed ID: 22334618
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Loss of PTEN expression by dermal fibroblasts causes skin fibrosis.
    Parapuram SK; Shi-wen X; Elliott C; Welch ID; Jones H; Baron M; Denton CP; Abraham DJ; Leask A
    J Invest Dermatol; 2011 Oct; 131(10):1996-2003. PubMed ID: 21654839
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Adenosine A(2A) receptors promote collagen production by a Fli1- and CTGF-mediated mechanism.
    Chan ES; Liu H; Fernandez P; Luna A; Perez-Aso M; Bujor AM; Trojanowska M; Cronstein BN
    Arthritis Res Ther; 2013; 15(3):R58. PubMed ID: 23663495
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CTGF/CCN2 from Skeletal Muscle to Nervous System: Impact on Neurodegenerative Diseases.
    Gonzalez D; Brandan E
    Mol Neurobiol; 2019 Aug; 56(8):5911-5916. PubMed ID: 30689195
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Deregulated expression of connective tissue growth factor (CTGF/CCN2) is linked to poor outcome in human cancer.
    Wells JE; Howlett M; Cole CH; Kees UR
    Int J Cancer; 2015 Aug; 137(3):504-11. PubMed ID: 24832082
    [TBL] [Abstract][Full Text] [Related]  

  • 46. CTGF/CCN-2 over-expression can directly induce features of skeletal muscle dystrophy.
    Morales MG; Cabello-Verrugio C; Santander C; Cabrera D; Goldschmeding R; Brandan E
    J Pathol; 2011 Dec; 225(4):490-501. PubMed ID: 21826667
    [TBL] [Abstract][Full Text] [Related]  

  • 47. CCN proteins: multifunctional signalling regulators.
    Perbal B
    Lancet; 2004 Jan; 363(9402):62-4. PubMed ID: 14723997
    [TBL] [Abstract][Full Text] [Related]  

  • 48. SMAD3 and SP1/SP3 Transcription Factors Collaborate to Regulate Connective Tissue Growth Factor Gene Expression in Myoblasts in Response to Transforming Growth Factor β.
    Córdova G; Rochard A; Riquelme-Guzmán C; Cofré C; Scherman D; Bigey P; Brandan E
    J Cell Biochem; 2015 Sep; 116(9):1880-7. PubMed ID: 25727481
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Regulation of Connective Tissue Growth Factor and Cardiac Fibrosis by an SRF/MicroRNA-133a Axis.
    Angelini A; Li Z; Mericskay M; Decaux JF
    PLoS One; 2015; 10(10):e0139858. PubMed ID: 26440278
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The carboxyl-terminal TSP1-homology domain is the biologically active effector peptide of matricellular protein CCN5 that counteracts profibrotic CCN2.
    Zolfaghari S; Kaasbøll OJ; Monsen VT; Sredic B; Hagelin EMV; Attramadal H
    J Biol Chem; 2023 Jan; 299(1):102803. PubMed ID: 36529291
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of Matricellular CCN Proteins in Skeletal Muscle: Focus on CCN2/CTGF and Its Regulation by Vasoactive Peptides.
    Rebolledo DL; Acuña MJ; Brandan E
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34063397
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Targeting CCN Proteins in Rheumatoid Arthritis and Osteoarthritis.
    MacDonald IJ; Huang CC; Liu SC; Lin YY; Tang CH
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33919365
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The CCN family of genes: a perspective on CCN biology and therapeutic potential.
    Yeger H; Perbal B
    J Cell Commun Signal; 2007 Dec; 1(3-4):159-64. PubMed ID: 18568428
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Analysis of Pathological Activities of CCN2/CTGF in Muscle Dystrophy.
    Acuña MJ; Brandan E
    Methods Mol Biol; 2017; 1489():513-521. PubMed ID: 27734402
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Emerging role of CCN family proteins in tumorigenesis and cancer metastasis (Review).
    Li J; Ye L; Owen S; Weeks HP; Zhang Z; Jiang WG
    Int J Mol Med; 2015 Dec; 36(6):1451-63. PubMed ID: 26498181
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ets-1 upregulation mediates angiotensin II-related cardiac fibrosis.
    Hao G; Han Z; Meng Z; Wei J; Gao D; Zhang H; Wang N
    Int J Clin Exp Pathol; 2015; 8(9):10216-27. PubMed ID: 26617730
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CCN2 plays a key role in extracellular matrix gene expression in severe hypertrophic cardiomyopathy and heart failure.
    Tsoutsman T; Wang X; Garchow K; Riser B; Twigg S; Semsarian C
    J Mol Cell Cardiol; 2013 Sep; 62():164-78. PubMed ID: 23756156
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Angiotensin II increases CTGF expression via MAPKs/TGF-β1/TRAF6 pathway in atrial fibroblasts.
    Gu J; Liu X; Wang QX; Tan HW; Guo M; Jiang WF; Zhou L
    Exp Cell Res; 2012 Oct; 318(16):2105-15. PubMed ID: 22749815
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Recombinant expression, purification, and functional characterisation of connective tissue growth factor and nephroblastoma-overexpressed protein.
    Bohr W; Kupper M; Hoffmann K; Weiskirchen R
    PLoS One; 2010 Dec; 5(12):e16000. PubMed ID: 21209863
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A mouse strain where basal connective tissue growth factor gene expression can be switched from low to high.
    Doherty HE; Kim HS; Hiller S; Sulik KK; Maeda N
    PLoS One; 2010 Sep; 5(9):e12909. PubMed ID: 20877562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.